Aspira Women's Health Inc.
AWHL· OTC
Released Mar 30, 2017, after the close
10-K filed Mar 31, 2017, 90 days after period end · 0000926617-17-000023
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $805.00K | $361.00K | $1.57M | $1.59M |
| Net Income | -$2.85M | -$4.98M |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$4.08M |
| -$1.82M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.